A new novolimus-eluting bioresorbable coronary scaffold: Present status and future clinical perspectives.
Sign Up to like & getrecommendations! Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2016.11.033
Abstract: The DESolve® scaffold (Elixir Medical Corporation, Sunnyvale, California, USA) is manufactured from a poly-l-lactide based polymer and elutes an anti-proliferative, anti-inflammatory drug, Novolimus from a poly-l-lactide based topcoat mixture. The strut thickness is 150μm and… read more here.
Keywords: new novolimus; bioresorbable coronary; coronary scaffold; novolimus eluting ... See more keywords